Medicine Information

VIOXX Lawsuits


Vioxx is a prescription medication that has been used primarily in the treatment of signs and symptoms of arthritis, but has also been prescribed to treat acute pain in adults and menstrual pain in women. It is a Cox-2 selective nonsteroidal anti-inflammatory drug or NSAID. Other Cox -2 selective NSAIDs on the market are Celebrex and Bextra. Vioxx is also related to nonselective NSAIDs such as ibuprofen and naproxen.

In September of 2004, its manufacturer, Merck & Co, voluntarily recalled Vioxx worldwide, due to safety concerns. The FDA issued a public advisory regarding the safety of Vioxx, though it was pulled from the market before the FDA had an opportunity to do a thorough review.

During a clinical trial in which Vioxx was being studied for its effectiveness for preventing the recurrence of colon polyps and as well as its long term safety, the study had to be halted because of the observed risk of increased cardiovascular risk after 18 months of continuous treatment with 25mg of Vioxx as opposed to those receiving a placebo (sugar pill). Merck pulled the drug from the market when the study confirmed longstanding concerns about the drug and demonstrated that the regular use of Vioxx doubled the patient's risk of heart attack or stroke if used regularly and for a prolonged period.

The FDA originally approved Vioxx in May 1999. At that time, their data, which included approximately 5,000 patients, did not indicate an increased risk for heart attack and strokes. However, later studies such as the one involving colon polyps, and another to study the effects of Vioxx upon stomach ulcers, show a correlation between the regular use of Vioxx and increased risk for heart attack or stroke.

After the recall of Vioxx, many doctors have recommended patients switch to other Cox-2 inhibitors such as Celebrex or Bextra, however, these medications have raised health concerns as well. Other patients have been advised to treat their symptoms with NSAIDs such as ibuprofen or naproxen.

Vioxx Help Center

The Vioxx MDL # is 1657: Section L. Correspondence with Judge Eldon E. Fallon may be sent to the following address:

Honorable Eldon E. Fallon
United States District Court,
Eastern District of Louisiana
500 Poydras Street, Room C-456
New Orleans, LA 70130
Tel:(504) 589-7545
Fax: (504) 589-6966
Web Site: Vioxx Product Liability

Wayne Walker is president of CapTran, the leader in litigation financial services. http://www.captran.com

© 2005 Capital Transaction Group Inc


MORE RESOURCES:

BioImagene CEO, Dr. Ajit Singh, Speaks On Enabling Personalized ...
MarketWatch - 10 hours ago
Digital pathology, a key enabler for personalized medicine, will aid clinicians in managing and interpreting data from a whole new set of diagnostic tests ...
Aperio Introduces SecondSlide(TM) Digital Slide Sharing Network MarketWatch
all 20 news articles


dBTechno

Medicine for the Job Market
New York Times, United States - 20 hours ago
By JONATHAN GRUBER A CENTRAL feature of Barack Obama’s presidential campaign was an aggressive plan to expand health insurance coverage by subsidizing ...
Reform or bust Barre Montpelier Times Argus
New Report Shows Slower Premium Growth, But Increasing Pressure to ... MarketWatch
What Does Health Care "Reform" Mean? How Soon Can We Get There? Part 1 Huffington Post
Harvard International Review - TMCnet
all 222 news articles


InjuryBoard.com

American College of Surgeons Comments on Institute of Medicine ...
MarketWatch - Dec 3, 2008
CHICAGO, Dec 03, 2008 /PRNewswire-USNewswire via COMTEX/ -- The American College of Surgeons (ACS) today recognized the Institute of Medicine (IOM) for its ...
BMC Internal Medicine Residency Program Achieves National ... iBerkshires.com
Does More Sleep Make for Better Doctors? New York Times
Report urges more sleep for medical residents Los Angeles Times
KELOLAND TV - Washington Post
all 334 news articles


Cardiogenesis and the Complex Biology of Regenerative ...
Science Magazine (subscription) - 4 hours ago
... for the development of human cell models of human disease and may lay the foundation for novel approaches in regenerative cardiovascular medicine. ...


Drug Topics Magazine

Drug Combo for Hypertension May Be Safer Than Recommended Alternative
New York Times, United States - 7 hours ago
(Many patients cannot control their blood pressure with just one medicine.) “The important message is that the government recommends a drug that provides 20 ...
Hypertension-drug mix cuts risk of serious ills Arizona Daily Star
Blood Pressure Pill Combo More Effective Than Diuretics Washington Post
Drug Combination Reduces Risk of Cardiovascular Events Combination ... Drug Topics Magazine
NJ.com - Medscape
all 28 news articles


Hyde Park Teen Ordered To Take Medicine
kypost.com, KY - 8 hours ago
A Hamilton County judge is ordering a Hyde Park teenager to take his medicine or face transfer to a more restrictive mental health facility. ...


Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
Washington Post, United States - 2 hours ago
... chairman of the ECOG leukemia committee and a professor of medicine at Northwestern University Feinberg School of Medicine and the Robert H. Lurie ...


Economic Medicine
Investor's Business Daily (subscription) - 1 hour ago
Taxes: President-elect Obama's plan to cut the capital gains tax rate on investments made in small and startup businesses could be the antidote our ailing ...


Mom's Cells Prime Fetal Immune System
U.S. News & World Report, DC - 7 hours ago
Dr. Rachel L. Miller, an associate professor of medicine and environmental health sciences at New York Presbyterian Hospital/Columbia University Medical ...
Researchers Make Key Discovery for Body to Accept Gene Therapy Newswise (press release)
all 9 news articles


Quality of Care in Medicine – Is It Improving?
HealthNews, CA - 4 hours ago
Everyone wants the best quality of medical care. Is our American health system quality of care high or low, and is it getting better or worse? ...

Medicine - Google News

home | index |site map
© 2006